P2‐431: Tobacco Smoking and Risk of Dementia: Evidence from the 10/66 Population‐Based Longitudinal Studies

Leonardo J. Otuyama,Ana R. Noto,Daysi Acosta,Juan J. Llibre Rodriguez,Y. Huang,Ivonne Z. Jimenez-Velazquez,Mariella Guerra,Aquiles Salas,Ana Luisa Sosa-Ortiz,Martin J. Prince,Cleusa Ferri

DOI: https://doi.org/10.1016/j.jalz.2016.06.1643

2016-01-01

Abstract:As the world population grows older and the number of people with dementia increases, studies that identify potential risk factors are important to inform strategies for prevention. Association between smoking and risk of dementia has been suggested, but findings are still inconsistent. To estimate the association between tobacco smoking and dementia using the same methodology in seven developing countries, testing the hypotheses that higher exposure to smoked tobacco is associated with a higher incidence of any dementia and with Alzheimer's disease (AD) and Vascular dementia (VaD) specifically. Secondary analysis of the 10/66 population-based cohort studies conducted with 13,483 dementia-free individuals aged 65 years and older from seven low and middle income countries who were followed-up for an average of four years. Cox regression with competing-risk analyses were used, controlling for age, gender, number of assets, past hazardous drinking, exercise and self report of angina and myocardial infarction. Exposure was measured as packyears and as smoking status (never, former, current and ever). Packyears was calculated by multiplying the average number of packs per day by years of consumption. Meta-analysis of the results from each country yielded non-significant pooled relative risk ratios for all comparisons made. There was no difference on risks for dementia between ‘ever smokers’ compared to ‘never smokers’ for any dementia (HR 0.96, 95% CI 0.82–1.13) and this was also the case for VaD and AD. ‘Current smokers’ had similar risk as ‘never smokers’ for any dementia (0.83, 0.66–1.06), for AD and VaD. ‘Former smokers’ had similar risk as ‘never smokers’ for any dementia (1.06, 0.88–1.27), for AD and VaD. We also compared the risk between ‘current smokers’ and ‘former smokers’ who had similar risk for any dementia (0.86, 0.66–1.13), for AD and VaD. Lifetime tobacco consumption (packyears) was not associated with any dementia (1.00, 0.99–1.00), and neither with AD and VaD. We found no risk association between smoking and the onset of dementia. However, we need to see these findings in the light of some limitations, since this was a short follow-up study, and bias such as survival and recall bias may have affected our findings.